decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / B-00-35
Subscribe or sign in to view the full article.
Article Overview
This program memorandum from HCFA explains a change affecting DMERC internal processing for an oral anti-cancer drug billing workflow. It is relevant to medical coders, billers, DMEPOS stakeholders, and compliance teams tracking HCFA program memorandum updates, NDC-related billing, and internal code set changes.
Why This Topic Matters
The article documents a payer-system change that affects how a specific oral drug source is identified in internal processing and when the update takes effect. Readers who work with DMERC, DMEPOS, and drug billing references can use it to understand the scope and timing of the memorandum without relying on the premium article.
What You Will Learn
- What change the program memorandum announces
- Which internal code identifiers were added
- How the memorandum relates to oral drug billing and DMERC processing
- When the change became effective and when it was implemented
Who Should Read This
- Medical coders
- Medical billers
- DMEPOS billing staff
- Compliance staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com